Takeda Pharmaceutical (TAK) Gets Priority Review. Can Zasocitinib Win in Psoriasis?

Reported by Yahoo Finance · Published 18 Sep 2026, 1:08 AM MYT (2 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

This is the only cybersecurity stock that can post big gains, according to one analyst 1 hr ago Kevin O’Leary says Congress will revisit CLARITY early next year as crypto tax bill advances 1 hr ago SEC opens door to tokenized U.S. stock trading. Here’s who could benefit 1 hr ago Securitize jumps after regulators greenlight some tokenized U.S. stock trading 1 hr ago Stocks making the biggest moves midday: Workday, Generac, Vital Farms, Vicor, Tower Semi & more 1 hr ago Amazon’s secret weapon against Walmart could be a massive blitz in same-day delivery 2 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Takeda Pharmaceutical (TAK) Gets Priority Review. Can Zasocitinib Win in Psoriasis?

Summary

More in Markets

This is the only cybersecurity stock that can post big gains, according to one analyst

Securitize jumps after regulators greenlight some tokenized U.S. stock trading

Stocks making the biggest moves midday: Workday, Generac, Vital Farms, Vicor, Tower Semi & more

Amazon’s secret weapon against Walmart could be a massive blitz in same-day delivery

AMD Jumps 7% as Semiconductor Rebound Reaches a Third Session; Broadcom Rises 3%, NVIDIA Edges Higher

BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million